izpis_h1_title_alt

Cathepsin L-mediated EGFR cleavage affects intracellular signalling pathways in cancer
ID Grozdanić, Marija (Author), ID Sobotič, Barbara (Author), ID Biasizzo, Monika (Author), ID Sever, Tilen (Author), ID Vidmar, Robert (Author), ID Vizovišek, Matej (Author), ID Turk, Boris (Author), ID Fonović, Marko (Author)

.pdfPDF - Presentation file, Download (4,88 MB)
MD5: 7D87F8EC9F49CB6F6B1FC5F06A622069
URLURL - Source URL, Visit https://www.degruyter.com/document/doi/10.1515/hsz-2023-0213/html This link opens in a new window

Abstract
Proteolytic activity in the tumour microenvironment is an important factor in cancer development since it can also affect intracellular signalling pathways via positive feedback loops that result in either increased tumour growth or resistance to anticancer mechanisms. In this study, we demonstrated extracellular cathepsin L-mediated cleavage of epidermal growth factor receptor (EGFR) and identified the cleavage site in the extracellular domain after R224. To further evaluate the relevance of this cleavage, we cloned and expressed a truncated version of EGFR, starting at G225, in HeLa cells. We confirmed the constitutive activation of the truncated protein in the absence of ligand binding and determined possible changes in intracellular signalling. Furthermore, we determined the effect of truncated EGFR protein expression on HeLa cell viability and response to the EGFR inhibitors, tyrosine kinase inhibitor (TKI) erlotinib and monoclonal antibody (mAb) cetuximab. Our data reveal the nuclear localization and phosphorylation of EGFR and signal transducer and activator of transcription 3 (STAT3) in cells that express the truncated EGFR protein and suggest that these phenomena cause resistance to EGFR inhibitors.

Language:English
Keywords:cancer, cysteine cathepsin, cathepsin L, EGFR, extracellular cleavage, resistance to TKIs
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:FKKT - Faculty of Chemistry and Chemical Technology
Publication status:Published
Publication version:Version of Record
Year:2024
Number of pages:Str. 283–296
Numbering:Vol. 405, iss. 4
PID:20.500.12556/RUL-155448 This link opens in a new window
UDC:577.2
ISSN on article:1431-6730
DOI:10.1515/hsz-2023-0213 This link opens in a new window
COBISS.SI-ID:171358723 This link opens in a new window
Publication date in RUL:02.04.2024
Views:96
Downloads:29
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Biological chemistry
Shortened title:Biol. chem.
Publisher:De Gruyter
ISSN:1431-6730
COBISS.SI-ID:1541908 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Projects

Funder:ARRS - Slovenian Research Agency
Project number:P1-0140
Name:Proteoliza in njena regulacija pri zdravju in boleznih

Funder:ARRS - Slovenian Research Agency
Project number:J1-1710
Name:Vloga cisteinskih katepsinov pri aktivaciji komplementa pri raku

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back